NEW YORK, NY, May 21, 2026 /24-7PressRelease/ — CD BioSciences, a trusted provider of specialized life science research solutions, has unveiled its full-spectrum anti-aging drug discovery services, empowering biotech and pharmaceutical clients to accelerate the development of novel therapies targeting aging-related biological processes and diseases.
Anti-aging drug discovery aims to identify and advance candidate drugs that delay age-related physiological decline and mitigate age-associated illnesses by targeting core aging mechanisms. CD BioSciences’ tailored anti-aging drug discovery services cover the entire research workflow, spanning target identification and validation, high-throughput screening, mechanism-of-action analysis, biomarker evaluation, and integrated in vitro and in vivo pharmacology studies. CD BioSciences focuses on pivotal aging-related pathways including cellular senescence, mitochondrial dysfunction, oxidative stress, nutrient sensing, and chronic inflammation, supporting research on key targets such as AMPK, SIRT1, mTOR, p53, and Nrf2.
A critical component of the service portfolio is the development and deployment of custom aging models for drug development. These customized in vitro and in vivo models accurately replicate age-related phenotypes and age-related pathological characteristics, enabling researchers to rigorously assess anti-aging mechanisms, validate biomarkers, and test the therapeutic potential of drug candidates. The flexible model design accommodates diverse drug types, including small molecules, biologics, peptides, and natural compounds, as well as specialized categories like senolytic drugs, antioxidants, autophagy inducers, and epigenetic modulators.
Beyond target and model support, CD BioSciences delivers one-stop solutions for anti-aging drug development. Its service scope extends to aging mechanism analysis, preclinical pharmacology research, ADME testing, and safety evaluation, forming a streamlined workflow from mechanistic exploration to preclinical progression. By integrating professional technical expertise and standardized experimental systems, CD BioSciences delivers high-quality, reliable research data to shorten the R&D cycle of promising anti-aging therapeutics and lower development risks for global clients.
As the demand for anti-aging and longevity therapies continues to grow across the biopharmaceutical industry, CD BioSciences remains committed to optimizing its anti-aging drug discovery services and refining custom aging models for drug development. CD BioSciences strives to drive innovation in aging research and support the translation of scientific discoveries into safe and effective clinical treatments for aging-related disorders.
About CD BioSciences
CD BioSciences is a preclinical research service provider focused on anti-aging drug development, offering one-stop solutions spanning drug discovery, pharmacology, pharmacokinetics, and safety evaluation. CD BioSciences leverages advanced platforms and extensive expertise in aging mechanism research, custom model development, and therapeutic evaluation to support pharmaceutical companies, research institutes, and academic investigators in advancing innovative anti-aging drug pipelines.
—
For the original version of this press release, please visit 24-7PressRelease.com here
Legal Disclaimer: The content on this page is syndicated from independent third-party providers. Kyrion Media makes no warranties or representations regarding the accuracy, completeness, legality, or reliability of the information, including text, images, videos, or licenses. If you are affiliated with this content or have any complaints, copyright concerns, or requests for removal, please contact us at retract@kyrionmedia.com with the specific URL of the content in question. We will review and address valid requests promptly.
